Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.
Saved in:
| Title: | Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. |
|---|---|
| Authors: | Yamada T; Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan., Nakamura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan. nakamura.nobuhiko.s1@f.gifu-u.ac.jp., Goto H; Department of Hematology, Chuno Kosei Hospital, Gifu, Japan., Hara T; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan., Kasahara S; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Fukuno K; Department of Hematology, Japanese Red Cross Takayama Hospital, Gifu, Japan., Sawada M; Department of Hematology, Japanese Red Cross Gifu Hospital, Gifu, Japan., Nakamura H; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Hayase N; Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan., Goto T; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Suzaki T; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan., Fujita K; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan., Lee S; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan., Kanemura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Shimizu M; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan., Tsurumi H; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan. |
| Source: | Annals of hematology [Ann Hematol] 2025 Oct; Vol. 104 (10), pp. 5191-5200. Date of Electronic Publication: 2025 Oct 10. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41068304 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yamada+T%22">Yamada T</searchLink>; Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+N%22">Nakamura N</searchLink>; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan. nakamura.nobuhiko.s1@f.gifu-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Goto+H%22">Goto H</searchLink>; Department of Hematology, Chuno Kosei Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Hara+T%22">Hara T</searchLink>; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Kasahara+S%22">Kasahara S</searchLink>; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuno+K%22">Fukuno K</searchLink>; Department of Hematology, Japanese Red Cross Takayama Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Sawada+M%22">Sawada M</searchLink>; Department of Hematology, Japanese Red Cross Gifu Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+H%22">Nakamura H</searchLink>; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Hayase+N%22">Hayase N</searchLink>; Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+T%22">Goto T</searchLink>; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Suzaki+T%22">Suzaki T</searchLink>; Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Kanemura+N%22">Kanemura N</searchLink>; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Shimizu+M%22">Shimizu M</searchLink>; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Tsurumi+H%22">Tsurumi H</searchLink>; Department of Hematology and Oncology, Matsunami General Hospital, Gifu, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2025 Oct; Vol. 104 (10), pp. 5191-5200. <i>Date of Electronic Publication: </i>2025 Oct 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41068304 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-025-06619-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5191 Titles: – TitleFull: Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yamada T – PersonEntity: Name: NameFull: Nakamura N – PersonEntity: Name: NameFull: Goto H – PersonEntity: Name: NameFull: Hara T – PersonEntity: Name: NameFull: Kasahara S – PersonEntity: Name: NameFull: Fukuno K – PersonEntity: Name: NameFull: Sawada M – PersonEntity: Name: NameFull: Nakamura H – PersonEntity: Name: NameFull: Hayase N – PersonEntity: Name: NameFull: Goto T – PersonEntity: Name: NameFull: Suzaki T – PersonEntity: Name: NameFull: Fujita K – PersonEntity: Name: NameFull: Lee S – PersonEntity: Name: NameFull: Kanemura N – PersonEntity: Name: NameFull: Shimizu M – PersonEntity: Name: NameFull: Tsurumi H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 104 – Type: issue Value: 10 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |